Total Funding
65
34
Total FundingPost-IPO Equity raised
Growth Score
-1 pts
Heat Score
-9 pts
Company Performance Metrics
Score
Trend
AI Content may contain mistakes and is not legal, financial or investment advice.Learn more.
Growth Score - The measure of growth based on company activity, operational metrics, and investments
Growth Trend - The change in the growth score over the given time period
Heat Score - The measure of the market interest, media activity, and Crunchbase profile activity
Heat Trend - The change in the heat score over the given time period
See more interactive data and historical milestones on desktop for the best experience
129809
T2 Biosystems is a biotechnology company that develops diagnostic products for rapid and accurate detection of various diseases.
Michael Cima: Co-Founder & DirectorPast Role: Springleaf Therapeutics, Founder
Brett Giffin: Chief Commercial Officer
About the Company
T2 Biosystems is a private company developing a next-generation medical diagnostic platform that enables rapid and accurate diagnostic tests of all types on a single, easy-to-use instrument. The company's proprietary technology combines nanotechnology and miniaturized magnetic resonance (MR) technology and eliminates the need for costly and
time-consuming sample preparation.
